Curium in Finland A legacy of excellence in nuclear medicine
Curium in Finland supports reliable access to nuclear medicine across Finland, Scandinavia and the Baltics through trusted local expertise and global capabilities.
Dedicated employees
Years' experience
Global customers
Countries
Manufacturing facilities
About Curium in Finland
For more than 20 years, Curium in Finland has supported healthcare providers with reliable radiopharmaceutical solutions, combining strong local expertise with the global capabilities of Curium.
Operating GMP-certified facilities in Helsinki and Tikkakoski, the company supports customers across more than 20 countries with a dedicated team of 80 employees committed to quality, reliability, and patient care.
A strong local foundation
Founded in 1991 as MAP Medical Technologies Oy, Curium in Finland has built a strong reputation for operational excellence and regulatory expertise. Since joining Curium in 2019, the company has further strengthened its ability to deliver high-quality radiopharmaceutical solutions across the region.
Reliable operations and supply
With three manufacturing facilities and wholesale distribution authorisation for medicinal products in Finland, Curium in Finland plays an important role in supporting consistent access to nuclear medicine throughout Scandinavia and the Baltics. Its operations are designed to ensure dependable supply, quality assurance, and efficient delivery to healthcare providers.
Connected to a global network
As part of Curium’s international organisation, Curium in Finland combines local knowledge with global scale, helping advance nuclear medicine through trusted partnerships, specialised expertise, and a shared commitment to improving patient care.
Curium products in Finland
Comprehensive radiopharmaceutical portfolio
Curium in Finland manufactures a growing portfolio of radiopharmaceutical solutions supporting both diagnostic imaging and targeted therapies.
Approved products include Pylclari and Fludeomap, while several innovative solutions are currently in development, including [18F] Sodium Fluoride (NaF) for injection, (18F) Fluorocholine chloride solution for injection, [177Lu] Lu-PSMA I&T solution for injection, and [225Ac] Actinium-PSMA I&T solution for injection.
Fludeomap
Fludeomap 250 MBq/ml solution for injection
F18-fludeoxyglucose
Cardiology, Infectious Diseases, Neurology, Oncology
GalenVita
GalenVita 0.74 –3.70 GBq radionuclide generator
Germanium (68Ge) chloride / gallium (68Ga) chloride
Radionuclide Generators
GalenVita in Finland
Indium (111In) Chloride
Indium (111In) Chloride Curiumpharma 370 MBq/ml radiopharmaceutical precursor
In111-chloride
Infectious Diseases, Oncology
Indium (111In) DTPA
Indium (111In) DTPA 37 MBq/mL solution for injection
In111-pentetate
Neurology
MIBG (I123)
MIBG (123.I) 74 MBq/mL solution for injection
Iobenguane
Oncology
Pulmocis®
Human albumin as macroaggregates 2 mg, kit for radiopharmaceutical preparation
macroaggregated human albumin (macrosalb)
Pulmonology
Pulmocis® in Finland
PYLCLARI®
PYLCLARI®
Piflufolastat (18F)
Oncology
Quadramet®
Quadramet, 1.3 GBq/mL solution for injection
Sm153-lexidronam
Oncology
Quadramet® in Finland
Renocis®
kit for radiopharmaceutical preparation
Succimer (dimercaptosuccinic acid)
Nephrology
Renocis® in Finland
Sodium Iodide I-131 Capsules Therapeutic
Sodium Iodide (131I) Capsules T 37-7400 MBq/mL hard capsule
Sodium iodide (¹³¹I)
Endocrinology, Oncology
Sodium Iodide I-131 Capsules Therapeutic in Finland
Sodium Iodide I123 Injection
Sodium iodide (123I) 37 MBq/mL solution for injection
I123-sodium
Endocrinology, Oncology
Stamicis®
Stamicis 1 mg kit for radiopharmaceutical preparation
[tetrakis (2-methoxyisobutyl isonitrile) copper (I)] tetrafluoroborate (sestamibi)
Cardiology
Stamicis® in Finland
Striascan™
Striascan 74 MBq/mL solution for injection
I123-ioflupane
Neurology
Teceos®
Teceos 13 mg kit for radiopharmaceutical preparation
Butedronate tetrasodium
Cardiology, Oncology
Technescan™ DMSA
Technescan DMSA 1.2 mg kit for radiopharmaceutical preparation
Succimer (dimercaptosuccinic acid)
Nephrology
Technescan™ DTPA
TechneScan DTPA 20.8 mg kit for radiopharmaceutical preparation
Pentetic acid
Nephrology, Neurology, Pulmonology, Urology
Technescan™ HDP
(Kit for the Preparation of Technetium Tc 99m Oxidronate Injection)
Sodium oxidronate
Musculoskeletal
Technescan™ MAG3
Technescan MAG3, 1 mg kit for radiopharmaceutical preparation
Mertiatide
Nephrology, Urology
Technescan™ PYP
Technescan MAG3, 1 mg kit for radiopharmaceutical preparation
Sodium pyrophosphate
Cardiology, Gastroenterology, Hematology
Technescan™ Sestamibi
Technescan Sestamibi 1 mg kit for radiopharmaceutical preparation
[Tetrakis (2-methoxy-2-methylpropyl-1 isocyanide)copper(I)] tetrafluoroborate
Cardiology, Endocrinology, Oncology
Thallous Chloride Tl 201 Injection
Thallous Chloride Tl 201 Injection
Tl201-Chloride
Cardiology, Endocrinology
Thallous Chloride Tl 201 Injection in Finland
Ultra Technekow™ FM
Ultra-Technekow FM 2.15-43.00 GBq radionuclide generator
Sodium molybdate (Mo-99)/sodium pertechnetate (Tc-99m)
Endocrinology, Radionuclide Generators
Vasculocis®
Vasculocis 10 mg kit for radiopharmaceutical preparation
human serum albumin
Cardiology
Healthcare Professional Access Restricted product information
The content within this section of the website is intended for registered healthcare professionals only. By proceeding, you confirm that you are a qualified healthcare professional and that you are accessing this information from your current country of practice.
Search Via Disease Areas
Cardiology 
Infectious Diseases 
Neurology 
Oncology 
Radionuclide Generators 
Pulmonology 
Nephrology 
Endocrinology 
Urology 
Musculoskeletal A World of Opportunities. Powered by Purpose.
Discover how your talent can thrive at Curium — where global purpose meets local impact, and every role helps shape the future of nuclear medicine.
Curium in Finland Locations
Finland
Country Headquarters
FI-00310 Helsinki
Finland
Helsinki (Kivihaka)
Sales Offices, Manufacturing Sites
Kivihaantie 7 F
FI-00310 Helsinki
Finland
Helsinki (Saukonpaasi)
Manufacturing Sites, PET Radiopharmacies
FI-00180 Helsinki
Finland
Tikkakoski
Sales Offices, Manufacturing Sites
FI-41160 Tikkakoski
Finland
Finland's Financial Contributions
2025
